Why the Aesthetic Device Industry Doesn't Want You to Hear This

Listen on

YouTube

Key takeaways

Q: Why are aesthetic device prices higher than most clinic owners realize?

A: Charles Donaldson explains that the gap between manufacturing cost and clinic invoice is wider than most owners assume — driven by distributor margins, regional exclusivity deals and sales incentives that get baked into the sticker price practices ultimately pay.

Q: What sales tactics should practice owners watch for when buying aesthetic devices?

A: Artificial urgency, bundled consumables that lock you into one supplier, leasing structures that obscure the true cost of capital, and trade-in offers that quietly destroy resale value. Slow the process down and price every component separately.

Q: How can clinics make smarter equipment decisions that protect their margins and their patients?

A: Treat device purchasing like a procurement function, not a sales conversation — get independent quotes, model true cost-per-treatment, validate clinical outcomes with peers, and never let a sales rep set the timeline for a six-figure decision.

Full transcript

A full transcript for this episode is coming soon.